Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis
European Journal of Neurology · 2023-10 · 30 (10) · 3068-3078
DOI: 10.1111/ene.15954 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 05.07.2023. Verfasst von D J L Stikvoort García und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neuron Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting ALS Nederland.
Abstract (Originalsprache)
Background and purpose The lack of reliable early biomarkers still causes substantial diagnostic delays in amyotrophic lateral sclerosis (ALS). The aim was to assess the diagnostic accuracy of a novel electrophysiological protocol in patients with suspected motor neuron disease (MND).
Methods
Consecutive patients with suspected MND were prospectively recruited at our tertiary referral centre for MND in Utrecht, The Netherlands. Procedures were performed in accordance with the Standards for Reporting of Diagnostic Accuracy. In addition to the standard diagnostic workup, an electrophysiological protocol of compound muscle action potential (CMAP) scans and nerve excitability tests was performed on patients' thenar muscles. The combined diagnostic yield of nerve excitability and CMAP scan based motor unit number estimation was compared to the Awaji and Gold Coast criteria and their added value was determined.
Results
In all, 153 ALS or progressive muscular atrophy patients, 63 disease controls and 43 healthy controls were included. Our electrophysiological protocol had high diagnostic accuracy (area under the curve [AUC] 0.85, 95% confidence interval [95% CI] 0.80–0.90), even in muscles with undetectable axon loss (AUC 0.78, 95% CI 0.70–0.85) and in bulbar‐onset patients (AUC 0.85, 95% CI 0.73–0.95). Twenty‐four of 33 (73%) ALS patients who could not be diagnosed during the same visit were correctly identified, as well as 8/13 (62%) ALS patients not meeting the Gold Coast criteria and 49/59 (83%) ALS patients not meeting the Awaji criteria during this first visit.
Conclusions
Our practical and non‐invasive electrophysiological protocol may improve early diagnosis in clinically challenging patients with suspected ALS. Routine incorporation may boost early diagnosis, enhance patient selection and generate baseline measures for clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Brain Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht, The Netherlands.
ORCID-Profile: D J L Stikvoort García, B T H M Sleutjes
Förderung
- Stichting ALS Nederland
Zitieren
APA
Stikvoort García, D. J. L., Sleutjes, B. T. H. M., van Schelven, L. J., Goedee, H. S., & van den Berg, L. H. (2023). Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis. European Journal of Neurology, 30(10), 3068-3078. https://doi.org/10.1111/ene.15954
Vancouver
Stikvoort García DJL, Sleutjes BTHM, van Schelven LJ, Goedee HS, van den Berg LH. Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis. European Journal of Neurology. 2023;30(10):3068-3078. doi:10.1111/ene.15954
BibTeX
@article{StikvoortGarca2023,
author = {Stikvoort García, D J L and Sleutjes, B T H M and van Schelven, L J and Goedee, H S and van den Berg, L H},
title = {Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis},
journal = {European Journal of Neurology},
year = {2023},
volume = {30},
number = {10},
pages = {3068--3078},
doi = {10.1111/ene.15954}
}
EUVIMED